Early Evaluation of Patient Risk for Substantial Weight Gain During Olanzapine Treatment for Schizophrenia, Schizophreniform, or Schizoaffective Disorder

BMC Psychiatry - United Kingdom
doi 10.1186/1471-244x-8-78
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search